GSK’s London-listed shares fell even more swiftly their ADRs to news that advisers to the Centers for Disease Control and Prevention shifted their recommendations for who should be vaccinated against respiratory syncytial virus.
Source: MarketWatch
Tuesday, 22. October 2024
Share:
27. June 2024 09:58
GSK stock falls more at London open following RSV vaccination news
